Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 884.44K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -4.64M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | 715.22k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -74.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -93.00% |
Recommedations | - | Quick Ratio | 0.01 | Shares Outstanding | 77.69M | 52W Low Chg | 35.00% |
Insider Own | 1.11% | ROA | -193.44% | Shares Float | 76.60M | Beta | -0.23 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.01 |
Gross Margin | 42.70% | Profit Margin | - | Avg. Volume | 1,534 | Target Price | - |
Oper. Margin | -1,047.35% | Earnings Date | Sep 26 | Volume | 20,000 | Change | 0.00% |
About AVIVAGEN INC
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.